Page 73 - วารสารการแพทย์แผนไทย ปีที่ 21 ฉบับที่ 2
P. 73

J Thai Trad Alt Med                                   Vol. 21  No. 2  May-Aug  2023  289




            Table 3  Comparison of clinical aspects of HCC between intervention and control groups on days 28, 56, 84, 112, and 140
              Clinical sign         Control group                   Intervention group        p-values
                        Day 28  Day 56  Day 84  Day 112  Day 140  Day 28  Day 56  Day 84  Day 112  Day 140
                        n = 13  n = 8   n = 7   n = 4    n = 1  n = 32  n = 21  n = 14  n = 9   n = 5
             Present Complaints
             Dyspepsia (VAS)  3.92 ±  7.17 ±  6.33 ±   6.00 ±   0   2.72 ±  5.05 ±  3.89 ±  3.43 ±  2.50 ±  0.83 †
                         3.09  2.84   1.53   2.83          3.38  3.27  2.62   3.46  2.89
             Appetite loss   1.67 ±  2.75 ±  4.00 ±    0   0   2.00 ±  2.92 ±  2.25 ±  3.00 ±  1.67 ±  0.93 †
             (VAS)       2.64  2.21   5.66                 3.44  3.37  3.41   4.12  2.89
             Fatigue    4.00 ±  5.50 ±  6.00 ±  6.00 ±   0   4.33 ±  4.71 ±  4.80 ±  3.28 ±  3.50 ±  0.32 †
             (VAS)       2.89  3.316  1.73   1.41          2.73  2.82  3.22   3.25  4.12
             Excretion
             every day   12      8     6      4      1     24     17    12     7      5    0.29 †
                        (92.31)  (100.00)  (85.71)  (100.00)  (100.00)  (75.00)  (80.95)  (85.71)  (77.78)  (100.00)
             2-3 times a day   0   0   1      0      0      6     2     2      2      0
                        (0.00)   (0.00)  (14.29)  (0.00)  (0.00)  (18.75)  (9.52)  (14.29)  (22.22)  (0.00)
             more than 3 days  1   0   0      0      0      2     2     0      0      0
                        (7.69)   (0.00)  (0.00)   (0.00)  (0.00)   (6.25)  (9.52)    (0.00)   (0.00)  (0.00)
             Sleep
              Normal     10      5     3      2      1     23     11    9      7      4    0.70 †
                        (76.92)  (62.50)  (42.86)  (50.00)  (100.00)  (71.88)  (52.38)  (64.29)  (77.78)  (80.00)
              Abnormal    3      3     4      2      0      9     10    5      2      1
                        (23.08)  (37.50)  (57.14)  (50.00)  (0.00)  (28.12)  (47.62)  (35.71)  (22.22)  (20.00)
             ECOG score,
             n (%)
              0           5      3     3      2      0      2     3     1      3      2    0.04 ‡
                        (71.43)  (37.50)  (75.00)  (66.67)  (0.00)  (13.33)  (14.29)  (14.29)  (50.00)  (100.00)
              1           0      1     0      1      0      2     1     1      2      0
                        (0.00)  (0.00)  (0.00)  (33.33)  (0.00)  (13.33)  (4.76)  (14.29)  (33.33)  (0.00)
             Tumor size (cm) (Tumor-related indicators), n (%)

               < 5        6      5     3      3      0      3     2     3      1      2    0.02 ‡
                          (100.00) (100.00)  (100.00)  (100.00)  (0.00)  (42.86)  (50.00)  (75.00)  (50.00)  (100.00)
               ≥ 5         0     0     0      0      0      4     2     1      1      0
                        (0.00)  (0.00)  (0.00)      (0.00)  (0.00)  (57.14)  (50.00)  (25.00)   (50.00)  (0.00)
             AFP (ng/ml), n (%)
              n          12      8     6      4      0     22     17    11     9      5    0.16 †

               < 400      3      2     1      0      0      9     8     5      5      3
                        (25.00)  (25.00)  (16.67)  (0.00)  (0.00)  (40.91)  (47.06)  (45.45)  (55.56)  (60.00)
               ≥ 400      9      6     5      4      0     13     9     6      4      2
                        (75.00)  (75.00)  (83.33)  (100.00)  (0.00)  (59.09)  (52.94)  (54.55)  (44.44)  (40.00)

                                  ‡
              †
               Multi-level model (Mixed model),   Generalized Estimating Equations (GEE)
   68   69   70   71   72   73   74   75   76   77   78